Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Importance of Multimodal Testing for Novel ALK Fusions: A Case of MTHFD1L‐ALK Positive Lung Squamous Cell Carcinoma With Negative IHC
Saved in:
| Published in: | Thoracic Cancer |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Importance of Multimodal Testing for Novel ALK Fusions: A Case of MTHFD1L‐ALK Positive Lung Squamous Cell Carcinoma With Negative IHC
- Prognostic Impact of ALK on Anaplastic Large Cell Lymphoma of CNS
- ALK expressing desmoid fibromatosis treated with Crizotinib: a clinical case
- First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
- Nodal Regulates Bladder Cancer Cell Migration and Invasion via the ALK/Smad Signaling Pathway [Retraction]
- Nanoparticle polymeric micellar paclitaxel compared with paclitaxel for advanced esophageal squamous cell carcinoma
- Female sex is associated with worse survival in laryngeal head and neck squamous cell carcinoma